[Hepatic dysfunction during antituberculosis treatment of HB antigens carriers].
作者信息
Pawlak F
出版信息
Pneumonol Pol. 1977 Sep;45(9):605-8.
PMID:928155
Abstract
摘要
相似文献
1
[Hepatic dysfunction during antituberculosis treatment of HB antigens carriers].
Pneumonol Pol. 1977 Sep;45(9):605-8.
2
[The impact of antituberculosis drugs upon liver function in patients with positive HBVM].[抗结核药物对乙肝病毒标志物阳性患者肝功能的影响]
Zhonghua Jie He He Hu Xi Za Zhi. 1989 Apr;12(2):89-90, 126.
3
4
[Combining antitubercular agents of similar hepatic toxicity].[联合使用具有相似肝毒性的抗结核药物]
Gruzlica. 1975 Jan;43(1):37-46.
5
[Protective effect of silibinin on liver injury induced by antituberculosis drugs].
Zhonghua Gan Zang Bing Za Zhi. 2010 May;18(5):385-6. doi: 10.3760/cma.j.issn.1007-3418.2010.05.019.
6
[Chemotherapy of pulmonary tuberculosis].[肺结核的化学疗法]
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi. 1984 Aug;7(4):194-7.
7
8
[Periarteritis nodosa with Australia antigenemia in the course of antituberculous treatment].抗结核治疗过程中伴有澳大利亚抗原血症的结节性多动脉炎
Pol Arch Med Wewn. 1974 Jun;51(6):645-52.
9
10
Clinical problems of tuberculostatic therapy and acute virus hepatitis.抗结核治疗与急性病毒性肝炎的临床问题
Acta Hepatogastroenterol (Stuttg). 1974 Dec;21(6):411-8.
Zotero 插件